VIRDY yields 1.32% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VIRDY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VIRDY + MRK for your $10,000?
Viridien Société anonyme provides data, products, services, and solutions in Earth science, data science, sensing, and monitoring in North America, Latin America, the Central and South Americas, Europe, Africa, the Middle East, and the Asia Pacific. It operates through two segments, Data, Digital & Energy Transition (DDE); and Sensing & Monitoring (SMO). The DDE segment engages in the geoscience business, which includes the processing and imaging of geophysical data, reservoir characterization, geophysical consulting and software services, geological data library, and data management solutions, as well as collecting, developing, and licensing geological data; earth data business, which comprises the development and management of a seismic and geological data library; development and sale of seismic data processing software under the Geovation brand; and provision of geoscience and petroleum engineering consulting services. Its SMO segment engages in the design, engineering, and manufacturing of seismic equipment for the land and marine seismic data acquisition, including seismic recording equipment, software, and seismic sources; and business equipment activities, such as land, marine, ocean bottom, borehole and beyond the core infrastructure monitoring solution and defense under the Sercel, Metrolog, GRC, DeRegt, and Geocomp brands. This segment also provides customer support services, such as training. The company was formerly known as CGG and changed its name to Viridien Société anonyme in May 2024. Viridien Société anonyme was incorporated in 1931 and is headquartered in Massy, France.
Full VIRDY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.